| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.25 | 2e-07 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |